TCTR20240529005Not yet recruitingPhase 3
Efficacy of melatonin to normalize the cytokines network and balance the oxidative stress in methamphetamine-induced psychosis patients: a double-blinded randomized controlled trial.
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
- Chulalongkorn University
- Enrollment
- 64
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Years to N/A (No limit) (—)
- Sex
- All
Inclusion Criteria
- •1. Participants are newly admitted to PMNIDAT and diagnosed with methamphetamine-induced psychosis.
- •2. Participants can have history of ultilization of alcohol and nicotine but methamphetamine must be the primary cause of psychosis.
- •3. Agree to take part in the study.
Exclusion Criteria
- •1. History of primary psychiatric disorders such as primary psychosis disorders, mood disorders, anxiety disorders, mild and major neurocognitive disorders.
- •2. History of autoimmune disorders and allergy to melatonin.
- •3. Currently have any allergic, infectious/inflammatory diseases, or have any signs or symptoms suggesting an allergic/infectious/inflammatory condition.
- •4. Currently receive any other treatments than the study experimental treatment.
- •5. Used other substance than methamphetamine, alcohol and nicotine in the last 1 month.
- •6. Female participants who currently get pregnant or practice breastfeeding.
Investigators
Similar Trials
Completed
Phase 2
The effect of melatonin on inflammatory cytokines in patients undergoing coronary artery bypass graft surgeryCoronary Artery Bypass Surgery.Atherosclerotic heart disease of native coronary arteryI25.1IRCT20141009019470N73Shiraz University of Medical Sciences42
Recruiting
Phase 3
Evaluation of the effect of melatonin on inflammatory factors and clinical outcomes in sepsissepsis.Other sepsisIRCT20181104041551N4Mazandaran University of Medical Sciences56
Completed
Phase 1
In this study we will see effects of melatonin tablets on S100B protein in delirium patientsCTRI/2019/12/022200King Georges Medical University73
Recruiting
Not Applicable
Melatonin in Depression or AnxietyIRCT20210921052540N1Tabriz University of Medical Sciences78
Not yet recruiting
Phase 3
Evaluation of the role of melatonin as a potential drug for prevention of delirium in patients who have been operated and are admitted in the intensive care unit.CTRI/2021/02/031183Dr Kriti Gupta